![]() |
Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging T. Marsden, N. McCartan, J. Hadley, S. Tuck, L. Brown, A.J. Haire, C.L. Moss, S. Green, M. van Hemelrijck, T. Coolen, A. Santaolalla, E. Isaac, G. Brembilla, D. Kopcke, F. Giganti, H. Sidhu, S. Punwani, M. Emberton, C.M. Moore, ReIMAGINE Study Group European Urology Focus 2021, 7 (3): 503-505 PubMed: 33896710 |
![]() |
An update from the ReIMAGINE Prostate Cancer Risk Study (NCT04060589): A prospective cohort study in men with a suspicion of prostate cancer who are referred onto a magnetic resonance imaging–based diagnostic pathway with donation of tissue, blood, and urine for biomarker analyses T. Marsden, H.U. Ahmed, M. Emberton, ReIMAGINE Study Group European Urology 2021, 80 (4): 398-399 PubMed: 34218972 |
![]() |
ReIMAGINE Prostate Cancer Screening Study: protocol for a single- centre feasibility study inviting men for prostate cancer screening using MRI T. Marsden, D.J. Lomas, N. McCartan, J. Hadley, S. Tuck, L. Brown, A. Haire, C.L. Moss, S. Green, M. Van Hemelrijck, T. Coolen, A. Santaolalla, E. Isaac, G. Brembilla, D. Kopcke, F. Giganti, H. Sidhu, S. Punwani, M. Emberton, C.M. Moore, ReIMAGINE Study Group BMJ Open 2021, 11 (9): e048144 PubMed: 34593491 |
![]() |
The ReIMAGINE prostate cancer risk study protocol: A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood and urine for biomarker analyses T. Marsden, N. McCartan, L. Brown, M. Rodriguez-Justo, T. Syer, G. Brembilla, M. Van Hemelrijck, T. Coolen, G. Attard, S. Punwani, C.M. Moore, H.U. Ahmed, M. Emberton, ReIMAGINE Study Group PLoS ONE 2022, 17 (2): e025967211 PubMed: 35202397 |